Alcohol "sensitivity" has been proposed as a predictive factor for development of alcohol dependence (Schuckit et al., 2005) . Most measures of alcohol sensitivity in humans and animals include a component that can be ascribed to acute functional tolerance (AFT). AFT is a form of tolerance that develops within a single period of alcohol exposure and has a genetic component. We used microarray technology as well as quantitative trait locus analysis of phenotypic and gene expression data across 30 BXD recombinant inbred strains of mice, 20 inbred strains of mice, and two replicate lines of mice selectively bred for differences in AFT, to identify differentially expressed candidate genes that contribute to predisposition to AFT. Eight candidate genes were identified by our statistical and filtering methods. The location of brain expression of these genes was mapped using the Allen Brain Atlas (http://www.brainmap.org), and the transcript location and molecular pathway analysis indicated that brain structures and biochemical pathways implicated in long-term potentiation and memory might also participate in the generation of acute functional alcohol tolerance.
The term ethanol (alcohol) tolerance refers to a decreased behavioral response to a given dose of alcohol after prior experience with alcohol or the need for a greater dose of ethanol to produce a given level of effect. Alcohol tolerance is an important diagnostic criterion for alcohol dependence in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (American Psychiatric Association, 1994) .
Functional (pharmacodynamic) alcohol tolerance manifests itself in three different forms: chronic (Tabakoff et al., 1986) , rapid (Khanna et al., 2002) , or acute (Mellanby, 1919) . Acute functional tolerance (AFT) refers to the tolerance that is manifested during a single session of alcohol drinking (Mellanby, 1919) , and it can start to develop within minutes after an individual starts to imbibe alcohol. The phenomenon of AFT was initially described by Mellanby (1919) through experiments that showed that humans display a greater degree of intoxication at a given blood alcohol concentration on the rising phase of the blood alcohol curve than at the same alcohol concentration on the falling phase of the blood alcohol curve. Acute functional alcohol tolerance is a neuronal resistance to alcohol effects (Tabakoff et al., 1986) ; however, its molecular mechanism is still not well characterized.
Sons of alcoholics (SOA) are three to five times more likely to develop alcohol dependence than sons of nonalcoholics (Cotton, 1979) . SOA also display less alcohol intoxication when measurements are made at least 1 h after drinking alcohol. The low level of response to alcohol has been found to predict future alcohol dependence (Schuckit et al., 2005) , and both men and women with no prior history of alcohol dependence, but with a positive family history of alcohol dependence, display a lower response to alcohol than those with no family history of alcohol dependence (Schuckit et al., 2005) .
Newlin and Thomson (1990) reviewed numerous studies and concluded that many of the measures of response to alcohol could be attributed to more rapid development of acute functional tolerance in the SOA subjects. This result suggests that AFT makes an important contribution to measures of the level of response to alcohol as reported by Schuckit et al. (2005) and may be a predictor for development of alcohol dependence.
AFT to the locomotor incoordinating effect of alcohol in mice can be measured using a stationary dowel test. The genetic influence on AFT in this particular test is demonstrated by studies of inbred and recombinant inbred (RI) mouse strains (Kirstein et al., 2002) , as well as by successful selective breeding of low AFT (LAFT) and high AFT (HAFT) mouse lines (Erwin and Deitrich, 1996) . Heritability for AFT has been estimated to range from 0.25 to 0.39 (Kirstein et al., 2002; Bennett et al., 2007) .
The genomic locations that contribute to AFT have been mapped using quantitative trait locus (QTL) analysis in 30 BXD RI strains and the progenitor strains (Kirstein et al., 2002) . However, specific genes contributing to AFT are still unknown. It is posited that if the expression level of a gene affects a phenotype, the expression of the gene should be regulated by a genetic element located within the phenotypic QTL for the phenotype, such as AFT. Therefore, we have also mapped expression QTLs (eQTLs) using gene expression data generated by microarray experiments in 30 BXD RI mouse strains and the progenitor strains (Saba et al., 2006) . We and others have previously used eQTLs to help identify candidate genes for complex phenotypes (Hubner et al., 2005; Wang et al., 2007) . In the present study, we use this procedure as a starting point to identify candidate genes that contribute to AFT.
Materials and Methods
Mice. Three types of male mice were used for our studies: 1) mice from 20 inbred strains (C57BL/6J, DBA/2J, 129P3/J, C3H/HeJ, AKR/J, A/J, BALB/cJ, FVB/NJ, SJL/J, BTBR Tϩ tf/J, C58/J, CBA/J, NZW/LacJ, 129S1/svlmJ, NOD/LtJ, PWD/PhJ, BALB/cByJ, KK/HlJ, MOLF/EiJ, and CAST/EiJ); 2) 30 BXD RI strains and the two progenitor strains (BXD1, BXD2, BXD5, BXD6, BXD8, BXD9, BXD11,  BXD12, BXD13, BXD14, BXD15, BXD16, BXD18, BXD19, BXD21,  BXD22, BXD23, BXD24, BXD27, BXD28, BXD29, BXD31, BXD32,  BXD33, BXD34, BXD36, BXD38, BXD39, BXD40, BXD42, C57BL/  6J , and DBA/2J); and 3) two replicate lines of mice selectively bred for high and low AFT (HAFT and LAFT mice). These lines were bred at the Institute for Behavioral Genetics (Boulder, CO) from HS/Ibg mice. Line 1 was in generation 24 and line 2 in generation 19 of selective breeding when used for our work. BXD RI mice and the mice from the 20 inbred strains were purchased from The Jackson Laboratory (Bar Harbor, ME). Food and water were provided ad libitum, and the mice were kept on a 12-h light/dark cycle. Animal use procedures were approved by the University of Colorado Health Sciences Center Institutional Animal Care and Use Committee. The inbred mice, BXD RI mice, and HAFT and LAFT mice were 55 to 90 days old when they were used for measures of AFT using the dowel test (see below) and for the microarray measurements of gene expression. We used six to 11 inbred mice per strain for the dowel test (64 DBA/2J mice were used as "internal controls" across time). For microarray analysis, four to seven mice per strain from inbred and BXD mice and four mice per group from the two lines of HAFT and LAFT mice were used. None of the mice used for microarray analysis was exposed to alcohol.
AFT Measurement. AFT to the locomotor incoordinating effect of alcohol was measured using the dowel test (Erwin and Deitrich, 1996) . In brief, mice were trained to balance on a wooden dowel rod for 5 min. On the test day, a mouse was given an i.p. alcohol injection of 1.75 g/kg (10% w/v) and was put on the dowel. When it fell off, a blood sample of 20 l was taken from the retro-orbital sinus for measurement of blood alcohol concentration (BEC) 0. A second blood sample was taken when the mouse regained the ability to balance on the dowel (BEC1). The mouse then received a second alcohol injection of 2 g/kg and was placed on the dowel. A third blood sample was taken when the mouse again regained the ability to balance on the dowel (BEC2). The difference between BEC1 and BEC2 was defined as the magnitude of AFT (Erwin and Deitrich, 1996) . Blood alcohol concentration was measured by gas chromatography (Tabakoff et al., 1976) .
Total RNA Extraction. Mice were killed by exposure to CO 2 for 10 to 15 s. The whole brain was removed rapidly (Ͻ2 min), and total RNA was isolated using the RNeasy Lipid Tissue Midi Kit (QIAGEN, Valencia, CA). RNA samples from each mouse brain were analyzed using a separate Affymetrix MOE430V2 array (Affymetrix, Santa Clara, CA).
Microarray Analysis. The quantitation of mRNA using the Affymetrix arrays was performed according to the protocol provided by Affymetrix and as previously described in our laboratories (Saba et al., 2006) . All arrays that were used for analyses passed the quality control procedures available on http://phenogen.uchsc.edu. Six microarrays were eliminated from the BXD panel and 15 microarrays were eliminated from the inbred panel because they did not meet the quality control requirements.
Some concern has been raised recently about the effect of single nucleotide polymorphisms (SNPs) within the 25mer represented by each probe on Affymetrix arrays on the hybridization of particular mRNAs. Walter et al. (2007) identified 13,292 probes within 6590 probesets that had a sequence polymorphism between C57BL/6J and DBA/2J mice. These probes were eliminated from all analyses, and if less than four probes within a probeset contained no SNPs, the entire probeset was eliminated. The Robust Multichip Average method, which includes a log base 2 transformation, was used to normalize the expression values of the perfect match probes and to summarize these values in probesets (Irizarry et al., 2003) . Each of the four experiments was normalized separately. For the BXD RI strains, only gene array data from the 28 strains, including the two parental strains, that had acute functional tolerance data available, were included in the normalization. All 20 inbred strains had acute functional tolerance data available, and expression data from all inbred strains were therefore included in the normalization. meta-Analysis. Correlation coefficients of gene expression values and AFT measurements in mice were calculated for each probeset in each of the four populations of animals. Correlation analysis between gene expression and AFT was performed with SAS version 9.1.3 (SAS Institute, Cary, NC). For the BXD RI panel and the inbred panel of mice, Pearson product-moment correlation coefficients were calculated using strain means for both gene expression values and AFT. For the two lines of HAFT and LAFT mice, a point biserial correlation was calculated for each line. Correlation coefficients were then transformed to their corresponding Z values (Field, 2001) . These transformed effect size values (Z values) were combined for each probeset using a weighted average, where weights were based on the variance of the particular experiment. Following the method outlined by Hedges and Vevea (1998) for a fixed effects model, a Z-score and its corresponding p value were calculated from the weighted average of the effect size values and its standard error. Raw p values were adjusted for multiple comparisons using the method for false discovery rates (FDR) outlined by Benjamini and Hochberg (1995) .
Expression QTL and AFT Behavioral QTL Analyses. Using gene expression as the quantitative trait of interest, eQTLs were calculated similarly to traditional QTLs. For this particular analysis,
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at ASPET Journals on April 1, 2017 jpet.aspetjournals.org eQTLs were calculated for each probeset individually using a weighted marker regression analysis. The analysis is weighted to account for difference in sample size within strain because strain means were used for the analysis (Saba et al., 2006) . Strain means were regressed against a set of 943 markers with unique strain distributions that were derived from the set of 3795 markers available at http://www.genenetwork.org/dbdoc/BXDGeno.html. Permutation was used to calculate p values associated with the maximal logarithm of the odds (LOD) score for each probeset, to account for the multiple comparisons across markers. The number of permutations per transcript was increased until the maximal LOD score from the true data was no longer in the top 10 LOD scores from the permutation, or until 1,000,000 permutations were calculated. A bootstrap method (see Saba et al., 2006) , using 1000 bootstrap samples, was used to determine 95% confidence limits for location of eQTLs with empirical p values less than 0.10 (see Supplemental  Table 1 and Supplemental Fig. 1 for a discussion of this methodology). All eQTL calculations were carried out with the freeware QTLReaper, which can be downloaded at http://sourceforge.net/projects/ qtlreaper/.
To generate the behavioral QTL (bQTL) data for AFT, we used our previously published AFT data on the 30 BXD RI strains and the two progenitor strains. QTLs were identified using marker regression on strain means and 1774 markers. QTL intervals were identified as a region covered by neighboring markers with a LOD score greater than 1.44 (p Ͻ 0.01), with a distal extension of 5 Mb on either side of the region.
Heritability. Narrow sense heritability (h 2 ) of each probeset was calculated within the BXD RI panel and the inbred panel separately using the method outlined by Hegmann and Possidente (1981) . This method assumes that the variance between inbred strains is twice the variance that would be seen in a random mating population [
, where V A is the variance between strain means and V E is the variance within strains.
Creation of Candidate Gene List. A list of candidate genes for AFT was created using multiple filters. The analysis was initially limited to probesets that had an eQTL that overlapped an AFT bQTL. The eQTL had to be significant or suggestive (empirical p value Յ0.10), with a 95% confidence interval for location that overlapped the location of one of the AFT bQTL regions, to pass this filter. For those probesets that passed the filter, an FDR was calculated based on the raw p values from the meta-analysis of correlation between expression level and AFT. Only probesets with an FDR less than 0.01 were retained. The third filter was implemented to ensure that the genes represented in the candidate gene list not only showed a strong genetic correlation with AFT, but also had a high heritability (above the overall median level of heritability) of expression intensities. Probesets were eliminated if the mRNA expression heritability in either the BXD RI panel or the inbred strain panel was lower than the median heritability of all probesets. Finally, the sequence alignment for the remaining probesets was examined using the Ensembl Genome Browser program (http://www.ensembl.org), and probesets, the sequence of which did not map appropriately to the transcript sequences they are purported to represent, were eliminated from consideration.
Examination of the Promoter Region of the Candidate Genes. Transcription factor binding sites within the upstream promoter region of AFT candidate genes were studied by using oPOSSUM (http://burgundy.cmmt.ubc.ca/oPOSSUM). Over-representation of transcription factor binding sites in a 2-kb upstream region (before the transcription start site) of the AFT candidate genes versus a precompiled background set of genes was determined using the Z-scores and Fisher's exact test p values generated by oPOSSUM.
Western Blot Analysis. Mouse brains were homogenized in 0.32 M sucrose, 50 mM Tris-HCl, 1 mM EDTA, and a protease inhibitor cocktail [4-(2-aminoethyl) benzenesulfonyl fluoride, pepstatinA, E-64, bestatin, leupeptin, and aprotinin (Sigma-Aldrich, St. Louis, MO)], pH 7.4, followed by centrifugation at 3,000g for 10 min to remove nuclei and debris. The supernatant was centrifuged at 45,000g for 1 h to pellet membranes. Membranes were resuspended in a buffer consisting of 1% SDS, 5% glycerol, 5% ␤-mercaptoethanol, 1 mM EDTA, 30 mM Tris-HCl, and 0.1% bromphenol blue, pH 6.8. Protein concentration was measured with the BCA assay (Thermo Fisher Scientific, Rockford, IL). After electrophoresis through 4 to 12% Bis-Tris gels (Invitrogen, Carlsbad, CA), proteins were transferred to nitrocellulose membranes. Anti-Kv2.1 antibody (SigmaAldrich) was used to probe the membrane at 1:250 dilution followed by goat anti-rabbit horseradish peroxide-coupled secondary antibody (Bio-Rad, Hercules, CA) at 1:5000 dilution. The chemiluminescence reagent was purchased from PerkinElmer Life and Analytical Sciences (Waltham, MA). ␤-Actin was used as a loading control.
Localization of Expression of the Candidate Genes in the Brain. We used the Allen Brain Atlas (http://www.brain-map.org) to obtain the expression levels of mRNA produced from our candidate genes in various brain areas. The Allen Brain Atlas contains expression levels for more than 20,000 genes in numerous brain regions of C57BL6/J mice. The data displayed by the Allen Brain Atlas were obtained using in situ hybridization as described in Lein et al. (2007) . The gene expression in coronal and sagittal sections is available, and 3-dimensional images for gene expression throughout brain areas can be obtained by using the software (Brain Explorer 1.4.1) available on the Allen Brain Atlas website (see Fig. 3 ). Because the results obtained from the Allen Brain Atlas can be considered semiquantitative, we chose to express the results in Table 3 in a format indicating relative levels of expression rather than absolute values. The symbols that we assigned to the expression values found on the Allen Brain Atlas site are as follows: 0 when the Atlas notes expression levels to be 0 to 15; ϩ when the Atlas notes expression levels to be 15.1 to 30; ϩϩ when the Atlas notes expression levels to be 30.1 to 50; ϩϩϩ when the Atlas notes expression levels to be 50.1 to 70; and ϩϩϩϩ when the Atlas notes expression levels to be 70.1 to 100. In Fig. 3 , the images are color-coded. Red indicates high expression, and green indicates low expression.
Biochemical Pathway Analysis. PathwayAssist software (Stratagene, La Jolla, CA) was used to examine the biochemical/ functional interaction of the AFT candidate genes. The software uses a database (ResNet Allen Brain Atlas; Stratagene) that contains more than 1.25 million events of regulation, interaction, and modification between and among proteins, cellular processes, and small molecules. ResNet is built from information extracted from PubMed abstracts and 47 full-text journals, and it is regularly updated.
Results
Measurement of AFT in Inbred Mice. We have previously published the data on the measures of AFT in the 30 strains of BXD mice and the parental strains (Kirstein et al., 2002) and in two replicate selectively bred lines of mice (HAFT1 and LAFT1, HAFT2 and LAFT2) (Saba et al., 2006) . In the present study, we measured AFT in the 20 inbred strains of mice using the same dowel test as used previously. The experiment on inbred strains was conducted at three time periods over 2 years. To control for systematic, chronologic bias, DBA/2J mice were included during each period as an internal control. Data in each period were standardized, i.e., adjusted for variation across each period, by an adjustment factor that was the average DBA/2J value across all three periods divided by the average DBA/2J value for a specific period. The data are shown in Fig. 1 . Analysis of variance showed a significant strain effect on AFT (p Ͻ 0.001). The CAST/EiJ strain was the strain with highest AFT, and the 129/P3J strain had the lowest AFT. These Reanalysis of AFT bQTLs Using BXD RI Mice. AFT bQTLs were previously determined in our laboratories using 30 BXD strains and two parental strains (Kirstein et al., 2002) . We were able to use more markers together with the behavioral AFT data that we published previously to redetermine AFT bQTLs. Marker locations that are used currently are from NCBI Mouse Build 36 (Ensembl). Six putative QTLs were detected that were located on chromosomes 1, 2, 4, 5, and 6 (Table 1) . QTLs on chromosomes 4 and 5 were not detected in our prior analysis. One QTL on chromosome 6 (27.6 -92 Mb) was identified as two separate QTLs in the previous analysis (Table 1 ). The marker D14Byu1 used to identify an AFT-QTL on chromosome 14 in our prior work (Kirstein et al., 2002) is currently no longer assigned to that location, and flanking markers are not associated with AFT. Therefore, no QTL for AFT is now reported on chromosome 14.
Using the recommendations of assigning the nomenclature of suggestive (LOD Ͼ1.9) and significant (LOD Ͼ3.3) to QTLs (Lander and Kruglyak, 1995) , all of the AFT QTLs that we identified should be considered suggestive. One QTL [chromosome (chr)6, 27.6 -92.0 Mb; LOD 3.1] is approaching significance.
AFT Candidate Genes. Our gene expression data obtained on Affymetrix arrays from all three types of animals are publicly available on http://phenogen.uchsc.edu, and an illustration of the distribution of levels of mRNA for Mtch2 and Kcnb1 across the 20 strains of inbred mice used in our studies is contained in Fig. 2 . Among 45,021 probesets on the Affymetrix MOE430V2 arrays (64 control probesets and the 16 probesets that had fewer than four probes without a SNP between C57BL/6J and DBA/2J mice were removed before Fig. 2 . Correlation analysis of expression levels of Mitch2 (B) and Kcnb1 (A) with AFT in whole brain areas of 20 strains of inbred mice. The expression levels are reported as the mean log 2 values from microarray analysis, and the strains are ordered in the same order as in Fig. 1 . The regression line and r values were derived using a Pearson product moment correlation analysis of the expression levels of these particular genes and AFT values from Fig. 1.   Fig. 1 . AFT measurement in the 20 inbred strains of mice using the dowel test. There were six to 11 mice per strain (64 DBA/2J mice were included as internal standards across time). Data are mean Ϯ S.E.M. Analysis of variance showed a significant strain effect on AFT (p Ͻ 0.001).
TABLE 1 Reanalysis of AFT bQTLs
The six provisional QTLs were identified for AFT using AFT measures and marker information from 30 BXD strains and two parental strains. Markers (SNPs from dbSNP) are noted as numbers preceded by rs. analysis), 5468 probesets were found to have a significant or suggestive eQTL (p Յ 0.1). A total of 1210 probesets had an eQTL overlapping one of the AFT bQTLs. Fifty of these 1210 probesets were significantly correlated with AFT, based on the meta-analysis of the four populations of animals (FDR Ͻ0.01). Among these 50 probesets, 13 had above median heritability in both the 20 inbred strains of mice (median ϭ 0.49) and the 32 strains of mice in the BXD panel (median ϭ 0.40). Sequence alignment on Ensembl showed that eight probesets aligned to the genes they were designed to represent, and the remaining five probesets did not. The eight genes were considered to be candidate genes for AFT ( Table  2 ). Some of the eight candidate genes were represented by more than one probeset on the Affymetrix arrays. In each case, one probeset passed all of the filters, whereas the additional probesets were eliminated at particular steps in the filtering procedure. Supplemental Table 2 provides information on the performance of each probeset targeted to each of the candidate gene mRNAs.
Markers
Examination of Brain Expression Patterns for Candidate Genes.
The mRNA for two of the eight candidate genes (Hlf and Cutl1) showed a broad distribution in brain (Table 3 ). This is not surprising, because the products of these genes act as transcription factors. The mRNA for WNK lysine-deficient protein kinase 1 (Wnk1), the serine-threonine kinase, also demonstrated a broad distribution indicative of the general importance of its function. On the other hand, the mRNA products of Epb4.1l2 and Kcnb1 were expressed together but localized at higher levels in cortical and hippocampal areas (Table 3 ; Fig. 3 ). Kcnb1 mRNA was also plentiful in the striatum (motor control function?) and thalamus (signal relay function). Mtch2 mRNA (Table 3) was highly expressed in the cerebellum and hippocampus, which are areas related to motor control and learning and memory, respectively.
Promoter Analysis of AFT Candidate Genes. Five transcription factor binding sites are over-represented within the 2000-basepair 5Ј-upstream region of the eight AFT candidate genes. The transcription factors are Elk1, Arnt-Ahr, Irf1, Creb1, and E2f1 (Z-score Ͼ4, Fisher's exact test, p Ͻ 0.05) ( Table 4) .
Western Blot Confirmation for Kcnb1 Protein Product. Kcnb1 is a promising candidate gene for AFT based on past (Lewohl et al., 1999) and current studies. KCNB1 protein levels were determined in HAFT/LAFT mice and in two strains of BXD mice. We chose BXD13 and BXD38 mice for protein quantitation because these two strains display significantly different levels of AFT (Kirstein et al., 2002 ). In our current study, we also noted significantly different Kcnb1 mRNA levels between HAFT1, HAFT2 and LAFT1, LAFT2 mice and between BXD 13 and BXD 38 mice. The results of Western blot analysis for KCNB1 protein are shown in Table   TABLE 2 Eight candidate genes for AFT Eight candidate genes were identified through the meta-analysis of brain microarray data from four populations of mice, using multiple filters. These genes were all negatively correlated with AFT. The FDR associated with the meta-analysis as well as the heritability of expression in the panels of inbred and recombinant inbred mice are reported. The candidate genes were required to have a significant or suggestive (p Յ 0.1) eQTL overlapping with an AFT bQTL. Fig. 4 . BXD 13 mice display high AFT levels and low Kcnb1 mRNA levels (9.19 Ϯ 0.06) compared with BXD 38 mice (log 2-transformed intensity value ϭ 9.95 Ϯ 0.05, p ϭ 0.00002). KCNB1 protein levels are also lower in the brain areas of BXD 13 mice (densitometric value ϭ 1.96 Ϯ 0.13) than in BXD 38 mice (densitometric value ϭ 2.52 Ϯ 0.11, p Ͻ 0.01). Kcnb1 mRNA is lower in HAFT1 mice (log 2-transformed intensity value ϭ 8.39 Ϯ 0.04) than in LAFT1 mice (9.13 Ϯ 0.13, p ϭ 0.002). KCNB1 protein is also lower in brain of HAFT1 mice (densitometric value ϭ 1.01 Ϯ 0.07) than in LAFT1 mice (densitometric value ϭ 1.22 Ϯ 0.07, p Ͻ 0.05). Pathway Analysis of the AFT Candidate Genes. Using PathwayAssist software, a relational pathway shown in Fig.  5 was generated. Five of the eight candidate gene products were included in this pathway, and there were a total of 16 gene products in the pathway.
Gene Name
meta-Analysis
Discussion
QTLs have been used extensively to locate the area of the genome that contributes to a quantitative phenotype. Gene expression can be conceptualized as an intermediate phenotype between DNA variation and quantitative differences in complex traits. If the expression level of a gene affects a behavior, which in turn is controlled by elements within a bQTL, one would expect that the candidate gene expression is also controlled from within the bQTL. We and others have recently used the overlap of eQTLs and bQTLs as a criterion to filter the candidate genes for alcohol-related traits (Saba et al., 2006) , atherosclerosis (Wang et al., 2007) , and hypertension (Hubner et al., 2005) from larger panels of differentially expressed genes.
After applying the eQTL/bQTL overlap filter and other filters, we identified eight genes as predisposing elements for AFT. Erythrocyte membrane protein band 4.1-like 2 (EPB41l2, or 4.1G) is a member of the cytoskeletal protein family that also includes 4.1R, 4.1N, and 4.1B. It is present in the postsynaptic density in neurons as well as in microglia in the brain. The 4.1G protein interacts with AMPA receptor glutamate receptor (GluR)1 and GluR4 subunits, and it may support their surface expression (Coleman et al., 2003) . It also interacts with D2 and D3 dopamine receptors (Binda et al., 2002) , metabotropic GluR subtype 1␣ (Lu et al., 2004a) , and A 1 adenosine receptors (Lu et al., 2004b) .
The voltage-gated potassium channel, Shab-related subfamily, member 1 (Kcnb1) is found on neuronal soma and proximal dendrites (reviewed in Trimmer and Rhodes, 2004) . Kcnb1 contributes significantly to the negative membrane potential, which dampens neuronal excitability. Another potassium channel, the calcium-gated potassium channel, has already been found to be necessary for the development of rapid tolerance to alcohol sedation in Drosophila (Cowmeadow et al., 2005) . Kcnb1 mRNA levels obtained using the Affymetrix MOE 430V2 arrays, across the 20 inbred strains of mice, are illustrated in Fig. 2 . Our measures of KCNB protein ( Fig. 4; Table 5 ) substantiated the inverse quantitative relationship between Kcnb1 gene products and AFT in the selectively bred HAFT and LAFT mice and in BXD recombinant inbred mice that differed in AFT. It is of interest that the genes related to scaffolding for the GluRs, and re- Wnk1 is a serine/threonine kinase. Wnk1 phosphorylates synaptotagmin 2 (Syt2), a Ca 2ϩ sensor, and increases the amount of Ca 2ϩ required for Syt2 binding to synaptic vesicles . Syt2 has been shown to be involved in the release of glutamate and other neurotransmitters (Pang et al., 2006) . Wnk1 also activates Erk5 , and Erk5 in turn activates calcineurin and down-regulates NMDA receptor activity. Thus, Wnk1 can modulate both presynaptic and postsynaptic components of glutamatergic transmission.
Cut-like 1 (Cutl1) generally functions as a transcription repressor, but it may also be a transcription activator (Nepveu, 2001) . It is mainly expressed in neurons in the upper layers of the murine brain cortex (Nieto et al., 2004) and may determine the neuronal phenotype of these neurons.
Hepatic leukemia factor (Hlf) protein is a basic-leucine zipper transcription factor. Reports on the function of Hlf protein in brain have linked the expression of Hlf to synaptogenesis in the cortex and thalamus (Hitzler et al., 1999) .
Mitochondrial carrier homolog 2 (Mtch2) is a mitochondrial membrane protein. Proteins such as Mtch2 have also been linked to promotion of neurite outgrowth (Lepagnol-Bestel et al., 2008) . The high expression of Mtch2 mRNA in the hippocampus and cerebellum may indicate a role for Mtch2 in rearrangement of neuronal architecture in brain areas important in spatial and motor learning and memory. Overall, it is of interest that a number of the candidate genes, including Epb4.1l2, Wnk1, Hlf, Kcnb1, and Mtch2, show high levels of expression in the brain areas implicated in learning and performance of motor skills, particularly the hippocampus, cerebellum, and cerebral cortex ( Fig. 3; Table 3 ).
The interactions noted in the literature among the products of the candidate genes we identified and other neuronal proteins indicate the importance of regulation of NMDA receptors with regard to AFT. Membrane depolarization upon AMPA receptor activation is generally required for NMDA receptors to open. Kcnb1 contributes to a negative membrane potential and therefore increases the difficulty of activating NMDA receptors. The negative correlation between Kcnb1 mRNA levels and AFT would suggest that NMDA receptors may be more active in animals that develop higher levels of AFT. The AMPA receptors undergo rapid trafficking (Shepherd and Huganir, 2007) . Normally, Epb4.1l2 supports AMPA receptors at the synapse. However, the mRNA levels of the splice variant of Epb4.1l2 that is negatively correlated with AFT in our studies does not contain a domain that binds actin and spectrin and thus may act as a "dominant negative" modulator of other Epb4.1 molecules. In essence, higher levels of Epb4.1l2 may decrease AMPA receptor surface expression and reduce the propensity for AFT development. Although not themselves differentially expressed, six receptor proteins (i.e., the products of genes Adora1, Drd2, Drd3, Grm1, Gria1, and Gria4) are coupled to the differentially expressed candidate genes through pathway analysis (Fig.  5 ). The products of these genes, including the subunits of the AMPA glutamate receptor, the metabotropic glutamate receptor 1, the D 2 and D 3 dopamine receptors, and the adenosine receptor 1␣, play a major role in excitatory and inhibitory signaling in the brain. On the presynaptic side of neurotransmission, the interaction of Wnk1 and Syt2 may be related to glutamate release (Pang et al., 2006) . The candidate gene product Wnk1 phosphorylates Syt2 and may reduce glutamate release, which could explain the negative correlation between Wnk1 mRNA and AFT in our analysis. It is of interest to note that our earlier microarray analysis of brains of HAFT and LAFT mice only, also implicated NMDA receptor systems in AFT, although different candidate genes were identified (Saba et al., 2006) .
Among the eight candidate genes, the expression of Epb4.1l2, Wnk1, and Hlf is trans-regulated from within bQTLs; the remaining genes, Kcnb1, Cutl1, Glcci1, Mtch2, and A130022J15Rik, seem to be cis-regulated (the eQTL information is available on http://phenogen.uchsc.edu). In particular, A130022J15 Rik is located within the bQTL on chromosome 6 that has a LOD score of 3.1. Although this gene is currently not well annotated, our results suggest that this gene would be of value to explore in terms of understanding the determinants of AFT. The eQTLs for all three trans-regulated genes are located on chromosome 2. The overlapping genomic area of these eQTLs (chromosome 2: 11.7-25.9 Mb) contains seven transcription factor Table 5.   TABLE 5 Comparison of protein levels and mRNA levels of Kcnb1 in mouse brain Western blot analysis of Kcnb1 protein was performed as described in the text. Densitometric measures were derived from images such as the ones illustrated in Fig. 4 . mRNA levels were obtained through analysis of Affymetrix MOE430V2 arrays. Data are mean Ϯ S.E.M. There were six mice/strain used in Western blot analysis and 4 to 6 mice/strain used in microarray analysis. BXD 13 mice display high AFT, whereas BXD 38 mice display low AFT. HAFT1/LAFT1 mice were selectively bred for high (HAFT) and low (LAFT) levels of AFT. A t test was used to compare expression values between BXD13 mice and BXD 38 mice and between HAFT1 mice and LAFT1 mice. (Bmyc, Nrarp, Sohlh1, Tbpl2, Bmi1, Ptf1a, and Pax8) . It would be appropriate to consider that one or more products of these transcription factor genes could influence the expression of the three trans-regulated candidate genes. However, the current lack of definitive data regarding DNA sequences that comprise binding sites for any of the seven transcription factors precludes a test of such a hypothesis. We did note that a Creb1 binding site was present in six of the eight candidate gene promoter regions, including all of the trans-regulated genes. The expression level of Creb1 was negatively correlated with AFT in our studies, but Creb1 was not included in our candidate gene list because it did not pass the eQTL/bQTL overlap filter. Although it is enticing to speculate about the involvement of Creb in neuroadaptive phenomena such as tolerance, the relation of Creb to the expression levels of our candidate genes is tenuous at present. A critical issue in evaluating our findings is whether they can be extrapolated across species. The human genome and mouse genome share a high level of synteny (Waterston et al., 2002) . The syntenic areas of mouse AFT bQTLs on chromosomes 2 (19.8 -30.4 Mb) and 6 (0 -17.4 Mb) overlap with two human alcohol dependence susceptibility loci (chromosome 7, 82.4 -94.9 Mb and chromosome 10, 26 -52 Mb) identified in the Collaborative Study on the Genetics of Alcoholism (Agrawal et al., 2008) . One of the AFT bQTLs (chromosome 1, 152.5-169.8 Mb) identified in mice is also syntenic with one of the human genomic loci (LOD Ͼ2 in 238 sibling pairs; marker at chromosome 1, 163 Mb) for a low alcohol response as measured by body sway and/or Subjective High Assessment Scale (Schuckit et al., 2005) . In addition, the mouse AFT QTL on chromosome 6 (27.6 -92.0 Mb; LOD ϭ 3.1) is syntenic with a human locus (chromosome 1, 71.9 Mb) that was reported to affect alcohol tolerance, as indicated by the quantity of alcohol that an individual could consume (Kuo et al., 2006) . We cannot be certain whether the human orthologs of our candidate genes for AFT play a role in human alcohol dependence susceptibility or the propensity for humans to develop AFT, but the candidate genes we identified in mice may well, with further investigation, help in understanding the molecular basis of acute alcohol tolerance in humans as well as rodents. Five of the eight candidate genes were included in the pathway through the computer analysis. These genes are shaded in orange and are circled. The full complement of proteins within the pathway was as follows: Drd2, Drd3, Grm1, Syt2, Kcnb1, Adora1, Gria1, Gria4, Wnk1, Cutl1, Epb4.1l2, Hlf, VGCC (voltage-gated calcium channel), PSD95 (postsynaptic density protein 95), G protein, and Grip (glutamate receptor-interacting protein). 
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